Worse patient VAS occurs at weeks 7 and 8 after infliximab infusions.
Shenker
N
N
Haigh
R
R
Clarke
A
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006304:Health Status; D006801:Humans; D000069285:Infliximab; D017060:Patient Satisfaction; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab